Shares of Divi’s Laboratories Ltd. went up by 0.39% to ₹5839.75 in Thursday’s trading session. During the day, the stock reached a high of ₹5900.00 and a low of ₹5815.80. The 52-week high for the stock is ₹6448.75, while the lowest it has been is ₹3350.05. As of 01:23 PM (IST), 458 shares were traded, totaling a value of ₹0.27 crore, according to Niftystat. The stock closed at ₹5863.00 in the previous session.
In the last month, the stock has fallen by 4.74%, while the BSE Sensex (a major index) dropped nearly 5%. The stock trades at a price-to-earnings (P/E) ratio of 84.38, which means investors think it has good potential for future growth. The price-to-book ratio is 6.71, showing how much investors are willing to pay for it even if the company isn’t growing.
Divi’s Laboratories belongs to the pharmaceutical industry. As of September 30, 2024, promoters own 51.89% of the company, while foreign institutional investors (FII) own 17.25% and mutual funds (MF) hold 11.92%.
In its latest report, the company announced consolidated sales of ₹2444 crore for the quarter ending September 30, 2024. This is an 11.24% increase from the previous quarter and a 22.51% rise compared to the same quarter last year. The company’s net profit for this quarter is ₹510 crore, which is a whopping 46.55% increase from the same time last year.
Leave a Reply